全文获取类型
收费全文 | 1384319篇 |
免费 | 107754篇 |
国内免费 | 8248篇 |
专业分类
耳鼻咽喉 | 17229篇 |
儿科学 | 44313篇 |
妇产科学 | 36908篇 |
基础医学 | 203041篇 |
口腔科学 | 36830篇 |
临床医学 | 136283篇 |
内科学 | 265013篇 |
皮肤病学 | 26731篇 |
神经病学 | 114265篇 |
特种医学 | 49923篇 |
外国民族医学 | 399篇 |
外科学 | 188720篇 |
综合类 | 39195篇 |
现状与发展 | 19篇 |
一般理论 | 462篇 |
预防医学 | 118451篇 |
眼科学 | 30253篇 |
药学 | 104710篇 |
74篇 | |
中国医学 | 7066篇 |
肿瘤学 | 80436篇 |
出版年
2021年 | 13921篇 |
2019年 | 13556篇 |
2018年 | 18209篇 |
2017年 | 14199篇 |
2016年 | 14972篇 |
2015年 | 17887篇 |
2014年 | 23889篇 |
2013年 | 34929篇 |
2012年 | 48418篇 |
2011年 | 51292篇 |
2010年 | 30132篇 |
2009年 | 27555篇 |
2008年 | 45619篇 |
2007年 | 47661篇 |
2006年 | 47674篇 |
2005年 | 45847篇 |
2004年 | 43191篇 |
2003年 | 41029篇 |
2002年 | 39586篇 |
2001年 | 61890篇 |
2000年 | 63436篇 |
1999年 | 53184篇 |
1998年 | 15129篇 |
1997年 | 13797篇 |
1996年 | 13544篇 |
1995年 | 12884篇 |
1994年 | 11958篇 |
1993年 | 11119篇 |
1992年 | 41798篇 |
1991年 | 40954篇 |
1990年 | 39601篇 |
1989年 | 37453篇 |
1988年 | 34708篇 |
1987年 | 33794篇 |
1986年 | 32222篇 |
1985年 | 30699篇 |
1984年 | 23062篇 |
1983年 | 19610篇 |
1982年 | 11770篇 |
1979年 | 20819篇 |
1978年 | 14822篇 |
1977年 | 12066篇 |
1976年 | 11877篇 |
1975年 | 12111篇 |
1974年 | 14800篇 |
1973年 | 14475篇 |
1972年 | 13358篇 |
1971年 | 12419篇 |
1970年 | 11488篇 |
1969年 | 10412篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
目的 探讨Hsa-miR-4282在肝癌细胞系SMMC-7721中的表达及其对细胞生长的影响。方法 采用实时荧光定量PCR法检测Hsa-miR-4282在人正常肝上皮细胞系HL-7702和人肝癌细胞系MHCC97-H、SMMC-7721,以及 20例肝癌组织及其相应癌旁组织中的表达。采用瞬时转染法将Hsa-miR-4282 mimics(上调组)和Hsa-miR-4282 inhibitor(下调组)分别转染肝癌SMMC-7721细胞,上调组和下调组分别设置相应阴性对照组。转染后采用MTT法检测细胞增殖能力,平板克隆形成实验检测细胞克隆形成能力,流式细胞仪检测细胞凋亡能力。结果 Hsa-miR-4282在肝癌组织、肝癌细胞MHCC97-H及肝癌细胞SMMC-7721中的表达均低于癌旁组织及正常肝细胞HL-7702(P<0.05)。MTT实验结果显示,Hsa-miR-4282上调后肝癌SMMC-7721细胞的OD值低于其阴性对照组,而下调后OD值高于其阴性对照组 (P<0.05)。平板克隆形成实验显示,下调组的细胞克隆数高于其阴性对照组[(240±7) 个 vs (191±10) 个,P=0.005)],而上调组细胞克隆数低于基阴性对照组[(146±10) 个 vs (193±12) 个,P=0.013)]。流式细胞仪检测结果显示,Hsa-miR-4282上调组细胞凋亡率较其阴性对照组升高[(23.89±1.89)% vs(16.6±1.14)%,P=0.009)],下调组细胞凋亡率较期阴性对照组降低[(14.98±0.46)% vs (17.79±0.73)%,P=0.010]。结论 Hsa-miR-4282上调可抑制肝癌SMMC-7721细胞增殖,促进细胞凋亡,可能与肝癌的发病机制有关。 相似文献
33.
34.
35.
36.
Breanne E. Kunstler Jill L. Cook Joanne L. Kemp Paul D. O’Halloran Caroline F. Finch 《Journal of Science and Medicine in Sport》2019,22(1):2-10
Objectives
To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.Design
Cross-sectional survey.Method
An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.Results
Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.Conclusions
Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy. 相似文献37.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20–25, 40–45, and 60–65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20–40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60–65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs. 相似文献
38.
39.